US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist

13.630
+0.130+0.96%

Trading Jul 5 14:35 ET

1.19BMarket Cap-5452P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-91.38%-49.73M

-33.66%-146.85M

-17.17%-41.37M

-59.66%-37.06M

-42.45%-42.43M

-20.51%-25.99M

-126.36%-109.87M

-168.13%-35.31M

-89.95%-23.21M

-122.19%-29.79M

Net income from continuing operations

-47.22%-62.41M

-32.87%-188.92M

-35.91%-54.51M

-22.11%-46.15M

-25.55%-45.86M

-52.78%-42.39M

-95.43%-142.18M

-82.83%-40.11M

-96.43%-37.8M

-136.07%-36.53M

Depreciation and amortization

30.34%116K

-27.87%383K

-42.78%103K

-40.00%99K

-30.83%92K

67.92%89K

166.83%531K

252.94%180K

230.00%165K

171.43%133K

Other non cash items

----

--3M

--0

----

Change In working capital

-83.74%1.22M

43.48%9.42M

412.84%3.8M

-114.19%-975K

-189.79%-879K

10,622.54%7.47M

143.56%6.56M

-133.38%-1.22M

278.36%6.87M

286.48%979K

-Change in prepaid assets

-35.85%884K

-262.53%-3.07M

-311.15%-1.16M

-154.93%-825K

25.78%-2.47M

223.47%1.38M

77.61%-846K

-48.40%547K

1,632.65%1.5M

-52.83%-3.32M

-Change in payables and accrued expense

-92.91%439K

66.17%12.89M

416.57%5.06M

-100.85%-46K

-61.42%1.69M

1,481.47%6.19M

16.54%7.76M

-161.31%-1.6M

176.55%5.44M

157.03%4.37M

-Change in other current liabilities

-12.50%-108K

-16.71%-405K

34.97%-106K

-52.94%-104K

-47.76%-99K

-95.92%-96K

-90.66%-347K

-482.14%-163K

-30.77%-68K

-31.37%-67K

Cash from discontinued investing activities

Operating cash flow

-91.38%-49.73M

-33.66%-146.85M

-17.17%-41.37M

-59.66%-37.06M

-42.45%-42.43M

-20.51%-25.99M

-126.36%-109.87M

-168.13%-35.31M

-89.95%-23.21M

-122.19%-29.79M

Investing cash flow

Cash flow from continuing investing activities

897.71%89.29M

150.33%128.38M

1,474.66%30.38M

136.02%88.92M

438.07%20.27M

-74,520.00%-11.19M

-3,088.43%-255.07M

-2.21M

-246.85M

-6M

Net PPE purchase and sale

--0

-761.54%-224K

---8K

-925.00%-41K

-2,028.57%-149K

-73.33%-26K

---26K

--0

---4K

---7K

Net intangibles purchase and sale

----

---3M

--0

----

--0

----

Net investment purchase and sale

899.57%89.29M

151.60%131.6M

1,475.02%30.39M

137.25%91.96M

440.95%20.42M

---11.17M

---255.05M

---2.21M

---246.85M

---5.99M

Cash from discontinued investing activities

Investing cash flow

897.71%89.29M

150.33%128.38M

1,474.66%30.38M

136.02%88.92M

438.07%20.27M

-74,520.00%-11.19M

-3,088.43%-255.07M

---2.21M

---246.85M

---6M

Financing cash flow

Cash flow from continuing financing activities

-95.95%48K

-1.15%164M

-68.87%597K

-94.40%115K

0.11%162.1M

1.18M

-44.16%165.9M

503.14%1.92M

433.82%2.05M

-3.92%161.93M

Net common stock issuance

----

-0.12%161.41M

--0

----

-3.25%161.61M

--0

----

Net preferred stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

-95.95%48K

-39.69%2.59M

-68.87%597K

-94.40%115K

116.25%692K

--1.18M

1,249.37%4.29M

503.14%1.92M

--2.05M

--320K

Cash from discontinued financing activities

Financing cash flow

-95.95%48K

-1.15%164M

-68.87%597K

-94.40%115K

0.11%162.1M

--1.18M

-44.16%165.9M

503.14%1.92M

433.82%2.05M

-3.92%161.93M

Net cash flow

Beginning cash position

170.68%230.78M

-70.01%85.26M

99.55%241.18M

-51.34%189.21M

-81.25%49.27M

-70.01%85.26M

550.18%284.31M

-59.33%120.86M

25.45%388.88M

69.65%262.73M

Current changes in cash

210.04%39.61M

173.11%145.52M

70.80%-10.4M

119.39%51.97M

10.94%139.94M

-66.81%-35.99M

-182.74%-199.05M

-177.04%-35.6M

-1,987.98%-268.01M

-18.68%126.15M

End cash Position

448.82%270.39M

170.68%230.78M

99.55%241.18M

-51.34%189.21M

-81.25%49.27M

-70.01%85.26M

-59.33%120.86M

25.45%388.88M

Free cash flow

-91.18%-49.73M

-36.56%-150.08M

-17.19%-41.38M

-72.73%-40.11M

-42.92%-42.58M

-20.54%-26.01M

-94.38%-109.9M

-168.13%-35.31M

-89.98%-23.22M

-122.24%-29.79M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-91.38%-49.73M	-33.66%-146.85M	-17.17%-41.37M	-59.66%-37.06M	-42.45%-42.43M	-20.51%-25.99M	-126.36%-109.87M	-168.13%-35.31M	-89.95%-23.21M	-122.19%-29.79M
Net income from continuing operations	-47.22%-62.41M	-32.87%-188.92M	-35.91%-54.51M	-22.11%-46.15M	-25.55%-45.86M	-52.78%-42.39M	-95.43%-142.18M	-82.83%-40.11M	-96.43%-37.8M	-136.07%-36.53M
Depreciation and amortization	30.34%116K	-27.87%383K	-42.78%103K	-40.00%99K	-30.83%92K	67.92%89K	166.83%531K	252.94%180K	230.00%165K	171.43%133K
Other non cash items	----	--3M	--0	----	----	----	----	----	----	----
Change In working capital	-83.74%1.22M	43.48%9.42M	412.84%3.8M	-114.19%-975K	-189.79%-879K	10,622.54%7.47M	143.56%6.56M	-133.38%-1.22M	278.36%6.87M	286.48%979K
-Change in prepaid assets	-35.85%884K	-262.53%-3.07M	-311.15%-1.16M	-154.93%-825K	25.78%-2.47M	223.47%1.38M	77.61%-846K	-48.40%547K	1,632.65%1.5M	-52.83%-3.32M
-Change in payables and accrued expense	-92.91%439K	66.17%12.89M	416.57%5.06M	-100.85%-46K	-61.42%1.69M	1,481.47%6.19M	16.54%7.76M	-161.31%-1.6M	176.55%5.44M	157.03%4.37M
-Change in other current liabilities	-12.50%-108K	-16.71%-405K	34.97%-106K	-52.94%-104K	-47.76%-99K	-95.92%-96K	-90.66%-347K	-482.14%-163K	-30.77%-68K	-31.37%-67K
Cash from discontinued investing activities
Operating cash flow	-91.38%-49.73M	-33.66%-146.85M	-17.17%-41.37M	-59.66%-37.06M	-42.45%-42.43M	-20.51%-25.99M	-126.36%-109.87M	-168.13%-35.31M	-89.95%-23.21M	-122.19%-29.79M
Investing cash flow
Cash flow from continuing investing activities	897.71%89.29M	150.33%128.38M	1,474.66%30.38M	136.02%88.92M	438.07%20.27M	-74,520.00%-11.19M	-3,088.43%-255.07M	-2.21M	-246.85M	-6M
Net PPE purchase and sale	--0	-761.54%-224K	---8K	-925.00%-41K	-2,028.57%-149K	-73.33%-26K	---26K	--0	---4K	---7K
Net intangibles purchase and sale	----	---3M	--0	----	----	----	--0	--0	----	----
Net investment purchase and sale	899.57%89.29M	151.60%131.6M	1,475.02%30.39M	137.25%91.96M	440.95%20.42M	---11.17M	---255.05M	---2.21M	---246.85M	---5.99M
Cash from discontinued investing activities
Investing cash flow	897.71%89.29M	150.33%128.38M	1,474.66%30.38M	136.02%88.92M	438.07%20.27M	-74,520.00%-11.19M	-3,088.43%-255.07M	---2.21M	---246.85M	---6M
Financing cash flow
Cash flow from continuing financing activities	-95.95%48K	-1.15%164M	-68.87%597K	-94.40%115K	0.11%162.1M	1.18M	-44.16%165.9M	503.14%1.92M	433.82%2.05M	-3.92%161.93M
Net common stock issuance	----	-0.12%161.41M	--0	--0	----	----	-3.25%161.61M	--0	--0	----
Net preferred stock issuance	----	--0	----	----	----	----	--0	----	----	----
Proceeds from stock option exercised by employees	-95.95%48K	-39.69%2.59M	-68.87%597K	-94.40%115K	116.25%692K	--1.18M	1,249.37%4.29M	503.14%1.92M	--2.05M	--320K
Cash from discontinued financing activities
Financing cash flow	-95.95%48K	-1.15%164M	-68.87%597K	-94.40%115K	0.11%162.1M	--1.18M	-44.16%165.9M	503.14%1.92M	433.82%2.05M	-3.92%161.93M
Net cash flow
Beginning cash position	170.68%230.78M	-70.01%85.26M	99.55%241.18M	-51.34%189.21M	-81.25%49.27M	-70.01%85.26M	550.18%284.31M	-59.33%120.86M	25.45%388.88M	69.65%262.73M
Current changes in cash	210.04%39.61M	173.11%145.52M	70.80%-10.4M	119.39%51.97M	10.94%139.94M	-66.81%-35.99M	-182.74%-199.05M	-177.04%-35.6M	-1,987.98%-268.01M	-18.68%126.15M
End cash Position	448.82%270.39M	170.68%230.78M	170.68%230.78M	99.55%241.18M	-51.34%189.21M	-81.25%49.27M	-70.01%85.26M	-70.01%85.26M	-59.33%120.86M	25.45%388.88M
Free cash flow	-91.18%-49.73M	-36.56%-150.08M	-17.19%-41.38M	-72.73%-40.11M	-42.92%-42.58M	-20.54%-26.01M	-94.38%-109.9M	-168.13%-35.31M	-89.98%-23.22M	-122.24%-29.79M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall